Brief: Trevena Reports Fourth Quarter And Full Year 2019 Results

Trevena

12/03/2020 11:22

March 12 (Reuters) - Trevena Inc  TRVN.O :
    * TREVENA REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS
    * Q4 LOSS PER SHARE $0.07
    * UPDATED GUIDANCE ON EXTENDED CASH RUNWAY, FUNDING
OPERATIONS
INTO Q1 2021
    * PDUFA DATE OF AUGUST 7, 2020 FOR IV OLICERIDINE; FDA
CONSIDERS
NDA RESUBMISSION COMPLETE
    * INITIATED PROOF-OF-CONCEPT STUDIES FOR ACUTE MIGRAINE
(TRV250)
AND OPIOID USE DISORDER (TRV734)
    * ANNOUNCES NIH COLLABORATION TO EVALUATE TRV045 FOR
EPILEPSY

Source text for Eikon:  ID:nGNXbJ5kXw 
Further company coverage:  TRVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))